The FYa and FYb antigens were reported in 1950 and 1951 respectively. Anti-FYa has been implemented in immediate and delayed Haemolytic Transfusion reactions and Haemolytic Disease in the new born. Indirect agglutination of red cells that carry the FYa - antigen occurs in the antiglobulin phase.  In the absence of the FYa- antigen, no indirect agglutination is generally observed. 

The Fortress Diagnostics Anti-FYa reagent consists of human monoclonal antibodies diluted in phosphate buffer containing sodium chloride and bovine albumin. The reagent requires no further dilution or addition for recommended techniques.


Product Name Number Kit Size
Anti-FYa BGFYA002 1 x 2ml

Request a Quote

Please get in touch to see how we can help

Contact Us Quote

Our website use cookies. By continuing to browse the site you are agreeing to our use of cookies. For more details about cookies and how to manage them see our Privacy & Cookies Policy